Indivior PLC (LON:INDV – Get Free Report)’s share price reached a new 52-week high on Thursday . The company traded as high as £1,453 ($1,794.71) and last traded at GBX 1,425 ($17.60), with a volume of 782614 shares traded. The stock had previously closed at GBX 1,514 ($18.70).
Indivior Stock Up 0.6 %
The business has a 50-day moving average price of GBX 1,619.74 and a two-hundred day moving average price of GBX 1,443.29. The company has a quick ratio of 1.52, a current ratio of 0.97 and a debt-to-equity ratio of 240.17. The firm has a market cap of £1.91 billion, a PE ratio of 140,800.00, a price-to-earnings-growth ratio of -5.57 and a beta of -0.05.
Insider Buying and Selling at Indivior
In other news, insider Mark Crossley sold 10,549 shares of the stock in a transaction dated Monday, March 18th. The shares were sold at an average price of GBX 1,617 ($19.97), for a total transaction of £170,577.33 ($210,693.34). 3.21% of the stock is currently owned by insiders.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- ESG Stocks, What Investors Should Know
- 3 Stocks Leading the U.S. Agriculture Comeback
- High Dividend REITs: Are They an Ideal Way to Diversify?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Market Cap Calculator: How to Calculate Market Cap
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
